The clonal and mutational evolution spectrum of primary triple-negative breast cancersSohrab P. Shah, J Costello, Andrew Roth et al.|Nature|2012Cited by 2k
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM StudyBella Kaufman, Alison Jones, John R. Mackey et al.|Journal of Clinical Oncology|2009Cited by 850
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerEvangelos D. Michelakis, John R. Mackey|British Journal of Cancer|2008Cited by 651
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic CancerJames J. Farrell, John R. Mackey|Gastroenterology|2008Cited by 448
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 TrialWilliam Greenhalf, Markus W. Büchler, Paula Ghaneh et al.|JNCI Journal of the National Cancer Institute|2013Cited by 333